The Foundation intends to provide preventions, treatments & cures for people affected by entire spectrum of retinal degenerative diseases.
The urgent mission of the Foundation Fighting Blindness, Inc. is to drive the research that will provide preventions, treatments and cures for people affected by retinitis pigmentosa (RP), macular degeneration, Usher syndrome, and the entire spectrum of retinal degenerative diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 27, 2022 | Grant | $5M | 1 |
![]() |
— | Detail |
Aug 2, 2016 | Grant | $109M | — | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 15, 2022
![]() |
Series B | $16.50M | Health Care | Yes |
Oct 21, 2020
![]() |
Series A | €44.50M | Biotechnology | — |
Apr 1, 2020
![]() |
Series A | $8.15M | Biotechnology | Yes |
Jun 1, 2019
![]() |
Series A | $21M | Biotechnology | — |
Apr 2, 2012
![]() |
Seed | $2M | Biotechnology | Yes |
Investor Name | Lead Investor | Funding Round |
---|---|---|
![]() |
Yes | Grant |
Foundation Fighting Blindness has had 1 exits. Foundation Fighting Blindness most notable exits include Vedere Bio ll
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Oct 29, 2020 | Vedere Bio ll | M&A | Biotechnology | Detail |